---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-152343"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2024-06-03T23:59:59+00:00"
generated_at: "2026-06-01T06:47:45.951293+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics receives Nasdaq delisting notice; trading to suspend June 4

## Summary
- Notice from Nasdaq on May 31, 2024 for failure to meet minimum market value, bid price, and publicly held shares requirements.
- Nasdaq will suspend trading of common stock (GRTX) at open on June 4, 2024.
- Company expects common stock to be quoted on OTC Markets under symbol GRTX.
- Company has the right to request a review of the Nasdaq Hearings Panel's decision.

## SEC filing metadata
- accession: 0001193125-24-152343
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2024-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312524152343/0001193125-24-152343-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312524152343/d758518d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-152343
- JSON: https://secwatch.observer/filing/0001193125-24-152343.json
- Plain text: https://secwatch.observer/filing/0001193125-24-152343.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.